Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
Pfizer is doing well enough to pay down debt while sustaining its generous dividend.
Oncology and specialty drugs are driving growth.
The stock has a high ceiling heading into next year.
10 stocks we like better than Pfizer ›
It's been a tough stretch for pharmaceutical giant Pfizer (NYSE: PFE). The company enjoyed a vaccine windfall during the COVID-19 pandemic, but revenue and profits cratered as the pandemic eased and those tailwinds stopped blowing. The stock has tumbled, sending Pfizer's dividend yield to a whopping 7.3%.
But Pfizer's stock price recently bounced on its second-quarter earnings. Investors have been looking for a glimpse into Pfizer's future, and there is a lot to like as things begin to come into view.
Here is why Pfizer's newfound momentum could set the stock up to soar in 2026.
Prudent financial management secures a generous dividend
Pfizer's generous dividend has become a big reason why many people consider owning the stock. It's not easy to find a 7.3% dividend yield, and oftentimes, stocks that do are yield traps with significant underlying risks.
While the market's negative sentiment toward Pfizer and the company's post-pandemic struggles have driven the share price down and the yield higher, the dividend itself is on solid footing. Management has raised the dividend for 15 consecutive years, so losing those pandemic-related profits didn't force a dividend cut. Additionally, the current dividend of $1.72 per share is well below the mid-point of management's 2025 adjusted EPS guidance of $3 per share.
In other words, Pfizer is still earning plenty of money to afford its dividend, and is using that cushion to, wisely, pay down debt to improve its balance sheet. That's prudent financial leadership, and should give investors some confidence that they can count on the stock's robust 7.3% yield as a nice baseline for the stock's future returns.
Is Wall Street sleeping on Pfizer's growth?
It seems the broader market is cautious toward healthcare stocks at the moment. Not only could tariffs raise costs for drug companies, but there is also pressure from the Trump administration to cut prescription drug prices for Americans.
However, Pfizer seems to be increasingly confident that it can navigate these headwinds and grow its business. Management recently raised its 2025 adjusted earnings guidance from a range of $2.80 to $3.00 per share to $2.90 to $3.10. The company has focused its growth efforts on oncology and specialty drugs, which are less likely to face pricing pressure. And that's precisely where Pfizer is growing the most; the company's specialty drug sales are up 6% year over year, and oncology sales are up 9% through six months of 2025.
As specialty and oncology drug sales increase, they should have a greater effect on Pfizer's overall growth. These two segments combined for approximately $16.5 billion through six months of this year. Pfizer's primary care drug sales, totaling $11.2 billion, are down 8% year over year as COVID-19 sales continue to fall off. Six-month sales of Pfizer's COVID-19 drugs are now less than $2 billion, so their impact on the numbers is drying up. Additionally, Pfizer's top seller, Eliquis, faces patent expiration but likely won't face generic competition until at least 2028.
Analysts only anticipate Pfizer earning $3.10 per share next fiscal year, but that could be too conservative, given Pfizer's momentum in oncology and specialty drugs and the resulting boost to this year's guidance. It seems tariff and political concerns are weighing on short-term expectations. If you zoom out, analysts anticipate Pfizer growing earnings at an annualized rate of 9% over the next three to five years, which seems to underline the good things happening in the business.
The conditions are ripe for a dramatic sentiment boost, making Pfizer a coiled spring at its current price
So, what does this all mean? There's an argument that Pfizer's stock could face a boost in sentiment if the dark clouds (tariffs and political pressure) clear out, allowing investors to refocus on Pfizer's growth in oncology and specialty drugs.
Today, Pfizer trades at just 8 times the midpoint of its 2025 earnings guidance. That valuation resembles a company on the verge of going under, not one that could grow at a high-single-digit pace over the coming years. Even if the valuation stays the same, Pfizer needs very little growth to generate double-digit investment returns because the dividend starts you off at over 7%.
If things do go well and Wall Street warms up to Pfizer, the stock could produce some seriously outsized returns from a lucrative trifecta of:
A 7.3% dividend
Potential high-single-digit growth
A valuation that could soar with some positive sentiment
It makes Pfizer a fantastic choice for income-focused investors, as well as bargain hunters looking for some upside in a market already trading at all-time highs, chugging toward 2026.
Should you invest $1,000 in Pfizer right now?
Before you buy stock in Pfizer, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!*
Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of August 4, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
4 hours ago
- Globe and Mail
Got $300 to Invest This August? Buy These Dividend Stocks and Never Look Back.
Key Points Brookfield Infrastructure owns a large, global collection of vital, cash-generating assets. Enterprise Products offers a high yield and steady dividend growth. Clearway Energy has visible growth through 2027 (and plenty of power to continue growing beyond that year). 10 stocks we like better than Enterprise Products Partners › Some dividend stocks are so reliable that you don't need to give them much thought. You can just buy shares and sit back and watch the dividend income consistently flow into your account. Brookfield Infrastructure (NYSE: BIPC)(NYSE: BIP), Enterprise Products Partners (NYSE: EPD), and Clearway Energy (NYSE: CWEN.A)(NYSE: CWEN) stand out to a few contributing analysts for their resilient dividend payments. Here's why they think you can park a few hundred dollars into these excellent dividend stocks this August and never look back. Brookfield Infrastructure is focused on cash cows Reuben Gregg Brewer (Brookfield Infrastructure): A $300 investment will get you roughly seven shares of Brookfield Infrastructure Corp. and a roughly 4.4% dividend yield. Or it will get you around nine shares of Brookfield Infrastructure Partners and a 5.4% yield. They represent the same entity, with the only difference being the structure. The corporate share class is more popular, which is why it trades at a higher price and, thus, has a lower yield. That said, Brookfield Infrastructure Partners, the older of the two classes, has increased its distribution annually for 18 years. Brookfield Infrastructure owns a globally diversified collection of infrastructure assets. There is a lot going on here, with the portfolio containing transportation and distribution utility assets, railroads, toll roads, transportation terminals, midstream assets (such as pipelines), and data transmission and storage assets. That's a lot of ground, and it positions Brookfield Infrastructure to produce reliable, recurring revenue backed by necessity businesses. The goal is to grow funds from operations by around 10% a year, with distributions pegged to grow between 5% and 9% a year. Brookfield Infrastructure is an active portfolio manager, however, constantly buying and selling assets. The big-picture plan is to acquire infrastructure assets while they are cheap, improve the value of assets via capital investment and astute operations, and then, if a good price can be had, sell the assets and repeat the process. Given the distribution record, this has been a solid playbook. If you are looking for a high yield backed by hard assets, this could be the pick for you in August. This 7% yield looks safe Neha Chamaria (Enterprise Products Partners): Enterprise Products Partners yields a solid 7%. However, that's not the reason to buy this dividend stock. It is the dividend track record, growth, and stability that make it one of the top 10 dividend stocks to buy now. Enterprise Products has increased its dividend for 27 consecutive years now. It's an oil and gas company, so one would expect Enterprise Products' cash flows to be volatile. That's not the case, though. As a pipeline company, Enterprise Products enjoys relatively inelastic demand, as it provides services under long-term contracts. While that ensures steady cash flows, the company prioritizes reinvesting into growth to grow its cash flows while returning capital to its shareholders. The judicious mix has made Enterprise Products' dividends very reliable over the years. Better yet, its dividends have grown consistently over the years, backed by growing cash flows. For instance, Enterprise Products' distributable cash flow (DCF) grew by 7% year over year in the second quarter. The company increased its dividend by 3.8%, and its DCF comfortably covered its dividend by 1.6 times. Management is excited about 2025 and beyond, as major projects worth $6 billion are expected to come online in the coming months, including a significant expansion of Enterprise Products' gas infrastructure in the Permian Basin. Meanwhile, Enterprise Products just struck a deal to acquire some of Occidental Petroleum 's natural gas-gathering systems in the Midland Basin. With $300 now, you can buy roughly nine shares of Enterprise Products Partners and enjoy its dividend growth and high yield, likely for years to come. Clear growth visibility through 2027 and beyond Matt DiLallo (Clearway Energy): Clearway Energy is a leading clean energy producer. The company operates a vast portfolio of wind, solar, energy storage, and natural gas assets. It sells the power generated by these clean energy assets under long-term contracts to utilities and large corporate customers. Those agreements provide it with stable, predictable cash flow, the bulk of which it pays to shareholders via dividends (nearly 6% current yield). At that rate, every $100 invested in Clearway would produce almost $6 of dividend income each year. The company uses its balance sheet flexibility and the cash it retains after paying dividends to invest in additional income-generating clean energy assets. Clearway has lined up several investments that provide it with significant visibility into its ability to grow its cash flow in the coming years. For example, it has agreed to invest in several wind repowering projects (replacing legacy turbines with larger ones that produce more power) it expects to complete in 2026 and 2027. It has also agreed to buy some renewable energy development projects as they enter commercial service over the next couple of years. Clearway's secured investments power its view that it can generate at least $2.50 per share of cash available for dividends (CAFD) in 2027 (up from $2.08 per share this year). That supports its plan to increase its dividend by 5% to 8% annually in the coming years. It recently raised its payment by another 1.6% to an annualized rate of $1.7824 per share. The company has an abundance of future growth opportunities, partly due to its strategic relationship with a leading renewable energy development company. It also has the financial capacity to continue making new investments. These factors drive its confidence that it can continue growing its CAFD and dividends per share at a rate of 5% to 8% annually, well beyond 2027. With visible growth through 2027 and more growth likely beyond that timeframe, you can confidently buy and hold Clearway for dividend income. Should you invest $1,000 in Enterprise Products Partners right now? Before you buy stock in Enterprise Products Partners, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Enterprise Products Partners wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
4 hours ago
- Globe and Mail
2 Government Initiatives That Could Propel Quantum Computing Stocks Like D-Wave Quantum, Rigetti Computing, and IonQ Higher
Key Points Investors see quantum computing as a potential game changer, similar to artificial intelligence. Many companies are still working to perfect the technology. Government programs and bills in Congress could unlock funding and lift the sector. 10 stocks we like better than Rigetti Computing › Other than artificial intelligence (AI), few sectors have seen a more meteoric rise over the past year than quantum computing. Quantum computers are expected to be a significant advancement from the traditional computer, with much more complex technology. Instead of using bits, the smallest form of digital data, quantum computers rely on qubits, which can house much more data than bits and have much higher computing power. Researchers believe quantum computers have the potential to solve some of the world's biggest issues. That's why quantum computing companies like D-Wave Quantum (NYSE: QBTS), Rigetti Computing (NASDAQ: RGTI), and IonQ (NYSE: IONQ) have seen their stocks fly, as they continue to make advancements on the technology. D-Wave and Rigetti are up over 1,800% over the past year, while IonQ is up over 500%. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » These stocks are still not generating significant revenue and are still losing money, while trading at multibillion-dollar market caps, so I think they will continue to be volatile and investors should keep positions smaller and more speculative for the time being. But here are two government initiatives that could propel the group higher. The Quantum Benchmarking Initiative (QBI) The Quantum Benchmarking Initiative (QBI) is being spearheaded by an independent U.S. Department of Defense agency called The Defense Advanced Research Projects Agency (DARPA), whose goal is to make sure the U.S. is prepared for technological challenges that might arise. The unit launched in 1957 after Sputnik, which marked the beginning of the space race between the U.S. and the Soviet Union. QBI's goal is essentially to determine if a quantum computer can be built to deliver a "utility-scale operation" in which its benefits exceed its cost. QBI hopes to do this by the year 2033. Companies can apply to go through a rigorous three-stage process. In the government's words: Stage A: Describe a utility-scale quantum computer concept that has a plausible path to realization in the near term. Stage B: Describe a Research and Development Plan capable of realizing the utility-scale quantum computer, the risks associated with that plan and the planned risk mitigation steps, and the prototypes needed to burn down these risks. Stage C: Work with the Government to Verify and Validate that their utility-scale quantum computer concept can be constructed as designed and operated as intended. In early April, DARPA selected 20 quantum computing companies for Stage A, which the agency described as a six-month sprint. Rigetti and IonQ were among those selected for Stage A. D-Wave was not selected because it is not focused on gate model quantum computing, but analysts at Needham believe industry momentum would certainly benefit the company, and I agree. Stage A should be completed some time in October based on the six-month timeline. Department of Energy Quantum Leadership Act of 2025 U.S. Sen. Richard Durbin, D-Ill., introduced the Department of Energy Leadership Act of 2025 into the Senate in February of this year, and the bill has been referred to the Committee on Energy and Natural Resources. According to Quantum Insider, the bill would increase research and development (R&D) for quantum information purposes including quantum computing. The bill could authorize as much as $2.5 billion in funding over five years, which would pair nicely with what DARPA is doing, and could further spur the quantum computing movement. The bill also seeks to establish regulations for working with other countries like China on quantum computing, clarify who can receive funding, and provide new goals and priorities for quantum technologies. Stocks like Rigetti, D-Wave, and IonQ would benefit from passage of this law if investors believe interest is increasing. If the U.S. government views quantum computing as necessary for national defense and solving core problems that impact all of mankind, investors are likely to get more interested. The bill also appears to have bipartisan support, with co-sponsors from both parties. A similar version of this bill failed to pass Congress in 2024, but now with the support of Schumer, bipartisan support, and the apparent interest from the Trump administration, given that it earmarked $250 million of funding in the "one big, beautiful bill" for quantum tech, the bill may drum up more support this time around. Should you invest $1,000 in Rigetti Computing right now? Before you buy stock in Rigetti Computing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
4 hours ago
- Globe and Mail
Amazon Stock Slips 10%: Here's Why It Can Still Finish 2025 With a Market Cap of $3 Trillion
Key Points Amazon stock is dipping because of slowing growth in AI. The company can greatly expand its margins in retail and e-commerce. The stock has a chance to grow to a $3 trillion market cap if 2026 earnings hit a level well within reach. 10 stocks we like better than Amazon › Last week, Amazon (NASDAQ: AMZN) reported its second-quarter earnings. Investors were not enthused. The stock dipped 10% and is now trailing the valuation of its big technology peers, with Nvidia and Microsoft having market caps of around twice the size of Amazon today. Wall Street is concerned about slower growth in cloud computing and Amazon falling behind in artificial intelligence (AI). This pins the stock down on one topic when in reality Amazon has all the ingredients to keep growing its profits over the long term, which is what will drive the share price higher. Here's why Amazon -- with a market cap of $2.3 trillion right now -- can finish 2025 valued at over $3 trillion. More profits arriving in e-commerce The biggest reason for Amazon's profit expansion in its e-commerce division the last few years is advertising. High-margin advertising revenue has grown from $7.4 billion in the second quarter of 2021 to $15.7 billion last quarter, and is still growing 22% year over year. This division has now generated $61 billion in revenue over the last 12 months and has incredibly strong profit margins. Advertising, along with growth in third-party seller services, subscription revenue, and operating leverage over its fixed cost base, has enabled Amazon's North American retail division to expand its profit margin to 7% over the last 12 months. Through the rest of 2025, there is plenty of room for this expansion to keep occurring, which will have a large impact on profitability given how much revenue the division generates ($400 billion over the last 12 months). Even slight profit margin enhancements mean billions of dollars in extra earnings for Amazon. The same thing is happening in international markets, where Amazon has a 3.4% operating margin on $150 billion in revenue. These segments are behind North America but have the same business model at the end of the day, meaning there is even more room for margin expansion over the long haul. Over $500 billion in annual revenue for segments growing revenue in the double digits means Amazon can add tens of billions of dollars in earnings power from North America and international retail in the years to come just by expanding its profit margin slightly each year. Through the rest of 2025, this story will continue to unfold. Sustained cloud computing tailwind A once shining star of Amazon's business, cloud computing division Amazon Web Services (AWS) was the reason for the stock falling after its latest quarterly result. Revenue grew 17.5% for AWS in the quarter, which was well behind competitors Microsoft and Alphabet. Even though AWS is growing slower than its peers, it will still benefit greatly from the AI revolution, especially because of its relationship with Anthropic. The fast-growing AI start-up is seeing booming revenue and is planning to spend a boatload of money at AWS, its key partner. This can drive an acceleration of revenue growth for AWS through the rest of 2025. With over $130 billion in annualized sales, AWS is on a path to hitting close to $150 billion in annual recurring revenue by the end of 2025. Its profit margin is also strong, at 37% over the last 12 months. A strong profit margin and fast revenue growth mean huge earnings gains for AWS, which will lead to consolidated earnings gains for Amazon. AMZN Operating Income (TTM) data by YCharts The math to a $3 trillion valuation Over the last 12 months, Amazon has generated $76 billion in operating income and $70 billion in net income. Through continued margin expansion in retail and fast growth at AWS, both of these figures can keep chugging higher through the end of 2025. In 2026, it is likely that Amazon's annual earnings will be close to or exceed $100 billion. Today, Amazon trades at a forward price-to-earnings ratio (P/E) of 33. The S&P 500 index trades at a P/E ratio of close to 30. A forward P/E ratio of 30 and $100 billion in 2026 earnings means that Amazon would trade at a market cap of $3 trillion by the end of this year. That is the math behind Amazon's potential in 2025, and why the stock is set to surge in the next few quarters. Buy Amazon stock and hold on tight for the long term. Should you invest $1,000 in Amazon right now? Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Brett Schafer has positions in Alphabet and Amazon. The Motley Fool has positions in and recommends Alphabet, Amazon, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
